Document detail
ID

oai:arXiv.org:2406.19567

Topic
Astrophysics - Instrumentation and...
Author
de Haan, Tijmen Collaboration, LiteBIRD
Category

sciences: astrophysics

Year

2024

listing date

7/3/2024

Keywords
nonlinearity litebird
Metrics

Abstract

Traditional methods of converting electronic readout counts to optical power incident on Transition Edge Sensors (TES) for Cosmic Microwave Background (CMB) observations involve a linear approximation.

For the upcoming LiteBIRD CMB satellite, strict nonlinearity requirements must be met to prevent contamination of the science band at 4f by the 2f signal, which arises from differential transmission or emissivity related to the half-wave plate's rotation rate fHWP.

These constraints cannot be met using hardware solutions alone and therefore require a form of nonlinearity correction.

We present MNTES, a novel physics-based, nonlinear calibration technique.

This method leverages our physical understanding of the TES power balance equation, accounts for imperfect voltage bias by casting the bias network as its Th\'evenin equivalent, and can incorporate external information such as time-varying magnetic fields and focal plane temperature variations.

The detector-specific parameters of MNTES will be measured during the ground calibration campaign prior to the LiteBIRD launch, yielding conversion functions that can take raw time-ordered data and output the reconstructed incident optical power.

MNTES will allow us to achieve LiteBIRD's goal of measuring the primordial tensor fluctuation spectrum to {\delta}r < 0.001.

;Comment: Conference proceedings of SPIE 2024: Astronomical Telescopes and Instrumentation

de Haan, Tijmen,Collaboration, LiteBIRD, 2024, MNTES: Modeling Nonlinearity of TES detectors for Enhanced Cosmic Microwave Background measurements with LiteBIRD

Document

Open

Share

Source

Articles recommended by ES/IODE AI

A rare case of localized peliosis hepatis during adjuvant chemotherapy including oxaliplatin mimicking a liver metastasis of colon cancer
peliosis hepatis metastatic liver tumor oxaliplatin oxaliplatin associated cancer metastatic tumor liver hepatis peliosis